FMP
Financial data for every need
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started
70,000+ Stocks with tons of data
Ready to Unlock Insights?
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
API Documentation
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
API Viewer
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Stock Prices
Real-time Prices, Historical Data and Indicators.
Stock Fundamentals
Financial Statements, Key Metrics, Stock Financial Scores and more.
Market News
Stock News, Press Releases and Experts Articles.
Company Information
Company Outlook, Market Capitalization, Company Core Information.
Data is collected only from trusted sources
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationFast, accurate, and developer friendly
We provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentation
Trusted by 100,000+ customers
Join us and get your API key
Latest News
Stay Updated and Harness the Power of Our API with the Latest News!
Jun 16, 2025 2:04 PM - Andrew Wynn
Twilio Inc. (NYSE:TWLO) Price Target and Market Position Analysis
Twilio Inc. (NYSE:TWLO) is a cloud communications platform that enables developers to build, scale, and operate real-time communications within software applications. The company provides a suite of APIs that allow businesses to integrate voice, messaging, video, and email capabilities into their ap...
Jun 16, 2025 2:00 PM - Alex Lavoie
Oxford Industries Inc. (NYSE:OXM) Director Increases Stake Amid Financial Challenges
On June 16, 2025, Chubb Thomas Caldecot III, the director, CEO, and President of Oxford Industries Inc. (NYSE:OXM), purchased 6,500 shares of the company's common stock at $40.12 each. This acquisition increased his total holdings to 59,063 shares. Oxford Industries, known for brands like Tommy Baha...
Jun 16, 2025 2:00 PM - Gordon Thompson
DoubleVerify Holdings, Inc. (NYSE: DV) Faces Legal Investigation Over Alleged Securities Law Violations
DoubleVerify Holdings, Inc. (NYSE: DV) is under scrutiny as Faruqi & Faruqi, LLP investigates claims on behalf of investors who suffered significant losses. The law firm is focusing on alleged violations of federal securities laws by DoubleVerify and its executives. These allegations include mislead...
Jun 16, 2025 1:02 PM - Alex Lavoie
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Faces Challenges but Shows Potential for Recovery
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biotechnology company focused on developing precision genetic medicines to treat rare diseases. The company is known for its work in the field of Duchenne muscular dystrophy (DMD) and other neuromuscular diseases. Sarepta's competitors include companies ...
Jun 16, 2025 1:00 PM - Rayan Ahmad
Piper Sandler Adjusts Roblox (NYSE:RBLX) Rating to "Overweight"
On June 16, 2025, Piper Sandler adjusted the grade of Roblox (NYSE:RBLX) to "Overweight." Despite being labeled as a downgrade, the grade remained "Overweight," with the stock price at approximately $100.17. Roblox is a prominent player in the gaming industry, known for its innovative platform that ...
Jun 16, 2025 12:04 PM - Tony Dante
UroGen Pharma Ltd. (NASDAQ:URGN) Faces Legal Challenges Amidst Optimistic Outlook
UroGen Pharma Ltd. (NASDAQ:URGN) is a biopharmaceutical company focused on developing innovative therapies for urological diseases. The company is known for its lead pipeline product, UGN-102, which is designed to treat low-grade upper tract urothelial cancer. UroGen competes with other pharmaceutic...
Jun 16, 2025 12:00 PM - Tony Dante
Sarepta Therapeutics Faces Challenges Amid Safety Concerns
Sarepta Therapeutics, trading under the symbol NASDAQ:SRPT, is a biotechnology company focused on developing innovative genetic medicines to treat rare diseases. The company is well-known for its work on therapies for Duchenne muscular dystrophy (DMD), a severe genetic disorder. However, Sarepta fac...
